Cyberounds Logo
December 12, 2018 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
The Role of Matrix Metalloproteinases (MMPs) in COPD
CME credit is no longer available for this conference.
Robert Foronjy, M.D., and Jeanine D'Armiento, M.D., Ph.D.

Dr. Foronjy is Assistant Professor of Medicine and Dr. D'Armiento is Associate Professor of Medicine, Columbia University, Department of Medicine, Division of Molecular and Pulmonary Medicine, New York.

Within the past 12 months, Drs. Foronjy and D'Armiento report no commercial conflicts of interest.

Albert Einstein College of Medicine, CCME staff and interMDnet staff have nothing to disclose.


Release Date: 06/29/2009
Termination Date: 06/29/2012

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • List the pathologic features of chronic bronchitis and emphysema
  • Discuss whether MMPs contribute to the development of COPD
  • Discuss if MMP inhibitors might effectively treat or prevent COPD.

 
The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
 
Please click below to accept the terms of this CME activity